These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 19440243)
1. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. Tanaka M; Oikawa K; Takanashi M; Kudo M; Ohyashiki J; Ohyashiki K; Kuroda M PLoS One; 2009; 4(5):e5532. PubMed ID: 19440243 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
3. Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia. Schotte D; Lange-Turenhout EA; Stumpel DJ; Stam RW; Buijs-Gladdines JG; Meijerink JP; Pieters R; Den Boer ML Haematologica; 2010 Oct; 95(10):1675-82. PubMed ID: 20494936 [TBL] [Abstract][Full Text] [Related]
4. [Preliminary analysis of aberrant expression of plasma miR-223 in pediatric acute lymphoblastic leukemia with a direct RT-PCR assay]. Lu XJ; Jiang Q; Huang PL; Li G; Zhang WJ; Zhao XX; Zheng HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):68-72. PubMed ID: 23484694 [TBL] [Abstract][Full Text] [Related]
5. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia. Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL. Ghodousi ES; Aberuyi N; Rahgozar S Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Mi S; Lu J; Sun M; Li Z; Zhang H; Neilly MB; Wang Y; Qian Z; Jin J; Zhang Y; Bohlander SK; Le Beau MM; Larson RA; Golub TR; Rowley JD; Chen J Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19971-6. PubMed ID: 18056805 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a as a marker of treatment response and survival in adult acute myeloid leukemia patients. Rashed RA; Hassan NM; Hussein MM Leuk Lymphoma; 2020 Oct; 61(10):2475-2481. PubMed ID: 32536234 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia. Ghodousi ES; Rahgozar S J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744 [TBL] [Abstract][Full Text] [Related]
10. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia. Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705 [TBL] [Abstract][Full Text] [Related]
11. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Shigoka M; Tsuchida A; Matsudo T; Nagakawa Y; Saito H; Suzuki Y; Aoki T; Murakami Y; Toyoda H; Kumada T; Bartenschlager R; Kato N; Ikeda M; Takashina T; Tanaka M; Suzuki R; Oikawa K; Takanashi M; Kuroda M Pathol Int; 2010 May; 60(5):351-7. PubMed ID: 20518884 [TBL] [Abstract][Full Text] [Related]
12. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia. Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522 [TBL] [Abstract][Full Text] [Related]
13. miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways. Fang ZH; Wang SL; Zhao JT; Lin ZJ; Chen LY; Su R; Xie ST; Carter BZ; Xu B Cell Death Dis; 2016 Sep; 7(9):e2371. PubMed ID: 27899822 [TBL] [Abstract][Full Text] [Related]
14. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. Ohyashiki JH; Umezu T; Kobayashi C; Hamamura RS; Tanaka M; Kuroda M; Ohyashiki K BMC Res Notes; 2010 Dec; 3():347. PubMed ID: 21182798 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells. Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of microRNA-145 down-regulation in adult T-cell leukemia/lymphoma. Xia H; Yamada S; Aoyama M; Sato F; Masaki A; Ge Y; Ri M; Ishida T; Ueda R; Utsunomiya A; Asai K; Inagaki H Hum Pathol; 2014 Jun; 45(6):1192-8. PubMed ID: 24745613 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia. Guo Y Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110 [TBL] [Abstract][Full Text] [Related]
18. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia. Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105 [TBL] [Abstract][Full Text] [Related]
19. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia. Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380 [TBL] [Abstract][Full Text] [Related]
20. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia. Sharifi M; Salehi R Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]